A detailed history of Clare Market Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clare Market Investments LLC holds 2,206 shares of LLY stock, worth $1.92 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
2,206
Holding current value
$1.92 Million
% of portfolio
0.4%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$727.2 - $932.06 $1.6 Million - $2.06 Million
2,206 New
2,206 $1.7 Billion
Q3 2024

Feb 20, 2025

BUY
$772.14 - $960.02 $733,533 - $912,019
950 Added 48.4%
2,913 $2.58 Billion
Q2 2024

Feb 20, 2025

BUY
$724.87 - $909.04 $218,910 - $274,530
302 Added 18.18%
1,963 $1.78 Billion
Q1 2024

Feb 20, 2025

SELL
$592.2 - $792.28 $38,493 - $51,498
-65 Reduced 3.77%
1,661 $1.29 Billion
Q4 2023

Feb 20, 2025

BUY
$525.19 - $619.13 $14,705 - $17,335
28 Added 1.65%
1,726 $1.01 Billion
Q3 2023

Feb 20, 2025

SELL
$434.7 - $599.3 $120,411 - $166,006
-277 Reduced 14.03%
1,698 $912 Million
Q2 2023

Feb 20, 2025

SELL
$350.74 - $468.98 $81,020 - $108,334
-231 Reduced 10.47%
1,975 $926 Million
Q1 2023

Feb 20, 2025

SELL
$310.63 - $364.82 $119,903 - $140,820
-386 Reduced 15.86%
2,048 $703 Million
Q4 2022

Feb 20, 2025

SELL
$321.55 - $374.67 $381,036 - $443,983
-1,185 Reduced 32.74%
2,434 $891 Million
Q3 2022

Feb 20, 2025

BUY
$296.48 - $337.87 $131,340 - $149,676
443 Added 13.95%
3,619 $1.17 Billion
Q2 2022

Feb 20, 2025

SELL
$278.73 - $327.27 $34,005 - $39,926
-122 Reduced 3.7%
3,176 $1.03 Billion
Q1 2022

Feb 20, 2025

SELL
$234.69 - $291.66 $321,994 - $400,157
-1,372 Reduced 29.38%
3,298 $945 Million
Q4 2021

Feb 20, 2025

SELL
$224.85 - $279.04 $30,129 - $37,391
-134 Reduced 2.79%
4,670 $1.29 Billion
Q3 2021

Feb 20, 2025

BUY
$221.6 - $272.71 $373,396 - $459,516
1,685 Added 54.02%
4,804 $1.11 Million
Q2 2021

Feb 20, 2025

SELL
$180.55 - $233.54 $255,478 - $330,459
-1,415 Reduced 31.21%
3,119 $716 Million
Q1 2021

Feb 20, 2025

SELL
$164.32 - $212.72 $11,995 - $15,528
-73 Reduced 1.58%
4,534 $847 Million
Q4 2020

Feb 20, 2025

BUY
$130.46 - $172.63 $601,029 - $795,306
4,607 New
4,607 $778 Million
Q3 2020

Feb 20, 2025

SELL
$146.22 - $169.13 $204,123 - $236,105
-1,396 Closed
0 $0
Q2 2020

Feb 20, 2025

SELL
$136.42 - $164.18 $110,500 - $132,985
-810 Reduced 36.72%
1,396 $229 Million
Q4 2019

Feb 20, 2025

BUY
$106.92 - $132.43 $307,929 - $381,398
2,880 Added 130.55%
5,086 $668 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $826B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.